JFG
FLNA

Jefferies Financial Group’s Filana Therapeutics FLNA Stock Holding History

Jefferies Financial Group’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-23,500
Closed -$55.5K – 1954
2024
Q4 		$55.5K Buy
23,500
+23,149
+6,595% +$407K ﹤0.01% 1493
2024
Q3 		$10.3K Buy
+351
New +$8.08K ﹤0.01% 1382
2024
Q2 		– Sell
-15,823
Closed -$334K – 1827
2024
Q1 		$321K Sell
15,823
-81,739
-84% -$1.88M ﹤0.01% 1194
2023
Q4 		$2.2M Sell
97,562
-139,463
-59% -$2.95M 0.01% 680
2023
Q3 		$3.94M Buy
237,025
+106,507
+82% +$2.11M 0.04% 405
2023
Q2 		$3.2M Sell
130,518
-3,016
-2% -$72.6K 0.03% 506
2023
Q1 		$3.22M Buy
133,534
+95,501
+251% +$2.65M 0.03% 506
2022
Q4 		$1.12M Buy
+38,033
New +$1.37M 0.01% 832

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jefferies Financial Group's FLNA Position: Q1 2025 in Review

Jefferies Financial Group sold out of Filana Therapeutics (FLNA) in Q1 2025, closing a stake of 23,500 shares — an estimated $55.5K sold.

Jefferies Financial Group first reported a position in FLNA in Q4 2022 and held it in 8 quarters. The position peaked at $3.94M in Q3 2023. 117 funds tracked by Wall St. Rank hold FLNA as of Q1 2025.

  • Jefferies Financial Group reported no remaining Filana Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Jefferies Financial Group sold 23,500 Filana Therapeutics shares in Q1 2025, an estimated $55.5K.
  • Jefferies Financial Group first reported a position in Filana Therapeutics in Q4 2022 and held it in 8 quarters.
  • Jefferies Financial Group's Filana Therapeutics position peaked at $3.94M in Q3 2023.
  • 117 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2025.

Based on Jefferies Financial Group's 13F filing for Q1 2025, filed 8 May 2025.